Clinical trial
Doses Systematic Per Oral Administration of Etamsylate Can Reduce Postpancreatectomy Hemorrhage From Pancreatic Stump in Pancreatogastrostomy
NCT06190535 is registered in ClinicalTrials.gov with University of Sfax as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Doses Systematic Per Oral Administration of Etamsylate Can Reduce Postpancreatectomy Hemorrhage From Pancreatic Stump in Pancreatogastrostomy
- Lead sponsor
- University of Sfax
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2024
- Completion date
- March 30, 2025
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
postpancreatectomy hemorrhage